impact factor, citescore
logo
In press
In Press
Recent issue
Recent issue
Recent Supplement
Recent supplement
archives
Archives
articles free
Free to view
Search
Search
 

Full Papers

 

Integrating treatment goals of patients, physicians, and payers: data from the prospective, open-label GO-MORE study of treatment with golimumab in patients with rheumatoid arthritis

1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11

 

  1. Hôpital Lapeyronie, Université Montpellier I, Montpellier, France
  2. St. Vincent’s University Hospital, Elm Park, Dublin, Ireland
  3. Cliditer S.A. de C.V. and Hospital General de Mexico, Mexico City, Mexico
  4. University of Debrecen Faculty of Medicine, Debrecen, Hungary
  5. Helsinki University Central Hospital, Helsinki, Finland
  6. Merck & Co., Inc., Kenilworth, NJ
  7. Merck & Co., Inc., Kenilworth, NJ
  8. Merck & Co., Inc., Kenilworth, NJ (Former)
  9. MSD Italy, Rome, Italy
  10. MSD Denmark, Ballerup, Denmark
  11. Merck & Co., Inc., Kenilworth, NJ (Former)

CER8469
Full Papers

Received: 20/03/2015
Accepted : 20/03/2015
In Press: 20/03/2015

Rheumatology Article